Faizana Fayaz

Faizana Fayaz

Auto-generated profile, based on publicly available information

Faizana Fayaz

Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research, Sector-3, MB Road, Pushp Vihar, Delhi 110017, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ASAnjali Sharma
Anjali Sharma
SWSharad Wakode
Sharad Wakode
FFFaizana Fayaz
Faizana Fayaz
SKShaik Khasimbi
Shaik Khasimbi
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
AKAvneet Kaur
Avneet Kaur
Piperazine scaffolds are a group of heterocyclic atoms having pharmacological values and showing significant results in pharmaceutical chemistry. Piperazine has a flexible core structure for the design and synthesis of new bioactive compounds. These flexible heterogenous compounds exhibit various biological roles, primarily anticancer, antioxidant, cognition enhancers, antimicrobial, antibacterial, antiviral, antifungal, antiinflammatory, anti-HIV-1 inhibitors, antidiabetic, antimalarial, antidepressant, antianxiety and anticonvulsant activities, etc. In the past few years, researchers focused on the therapeutic profile of piperazine synthons for different biological targets. The present review highlights the development in designing pharmacological activities of nitrogen-containing piperazine moiety as a therapeutic agent. The extensive popularity of piperazine as a drug of abuse and their vast heterogeneity research efforts over the last years motivated the new investigators to further explore this area.

26 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
BKBhumika Kumar
Bhumika Kumar
MPMukesh Pandey
Mukesh Pandey
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
FFFaizana Fayaz
Faizana Fayaz
ASAnjali Sharma
Anjali Sharma
PSP.K. Sahoo
P.K. Sahoo
Parkinson’s disease is one of the most severe progressive neurodegenerative disorders, having a mortifying effect on the health of millions of people around the globe. The neural cells producing dopamine in the substantia nigra of the brain die out. This leads to symptoms like hypokinesia, rigidity, bradykinesia, and rest tremor. Parkinsonism cannot be cured, but the symptoms can be reduced with the intervention of medicinal drugs, surgical treatments, and physical therapies. Delivering drugs to the brain for treating Parkinson’s disease is very challenging. The blood-brain barrier acts as a highly selective semi-permeable barrier, which refrains the drug from reaching the brain. Conventional drug delivery systems used for Parkinson’s disease do not readily cross the blood barrier and further lead to several side-effects. Recent advancements in drug delivery technologies have facilitated drug delivery to the brain without flooding the bloodstream and by directly targeting the neurons. In the era of Nanotherapeutics, liposomes are an efficient drug delivery option for brain targeting. Liposomes facilitate the passage of drugs across the blood-brain barrier, enhances the efficacy of the drugs, and minimize the side effects related to it. The review aims at providing a broad updated view of the liposomes, which can be used for targeting Parkinson’s disease.

18 December 2020 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
ASAnjali Sharma
Anjali Sharma
SWSharad Wakode
Sharad Wakode
SSSupriya Sharma
Supriya Sharma
FFFaizana Fayaz
Faizana Fayaz
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
Green chemistry plays an important role in the development of sustainable production systems which involves tremendous research efforts on the design of synthetic and analytical techniques through resource-efficient ways. The improvement in synthetic reaction performances encourages the modern society to minimize energy and reagent consumption and waste generation. Explosion of the chemicals are referred as extremely toxic substances and have been allied with major harmful health effects, though no cure has been established due to the lack of curative therapeutic approaches. In view of the facts, green chemistry strategies trigger a new hope in the synthesis of safer biologically active compounds to meet the demands of disease free environment. Here, we highlighted the development of various compounds and greener techniques such as ultrasoundassisted method, microwave-assisted method, green solvent reactions, solvent free reactions, biomolecules and nanoformulations as a new healthy approach.

14 September 2021 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
JMJayanti Mishra
Jayanti Mishra
BKBhumika Kumar
Bhumika Kumar
MPMukesh Pandey
Mukesh Pandey
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
FFFaizana Fayaz
Faizana Fayaz
PSPravat K. Sahoo
Pravat K. Sahoo
Background: Alzheimer’s disease is an irreversible, progressive brain disorder manifested with symptoms like loss of memory (known as dementia), personality changes, loss of cognition, impaired movement, confusion, deteriorated planning and thought process. Neurodegeneration in Alzheimer’s disease is the result of deposition of protein beta-amyloid that forms plaques and another protein called tau, forming tangles that prevent proper functioning of nerve cells in the brain. Methods: The goal of the review was to comprehensively study the utilization of nanotechnology and the role that carbon nanotubes can play as a drug delivery system for amelioration of Alzheimer’s disease. Results: Nanotechnology is one of the most researched domains of modern science. It contributes significantly to therapeutics by facilitating drug therapy to reach the target sites, which are otherwise difficult to reach with conventional drug delivery systems. Carbon nanotubes are the allotropes of carbon in which several carbon atoms bind with each other to form a cylindrical or a tube-like structure. The carbon nanotubes possess several unique qualities, which confer them with a high potential of being utilized as an efficient drug delivery system. They offer high drug loading and can readily cross the toughest biological barriers like the BBB. Carbon nanotubes also facilitate the passage of drugs to the brain via the olfactory route, which further helps in restoring normal autophagy, thus preventing the elimination of autophagic chemicals. They can carry a vast range of cargos, including drugs, antigens, genetic materials, and biological macromolecules. Conclusion: Carbon nanotubes are a highly promising drug delivery system for anti-Alzheimer’s drugs. They have the potential of overcoming the various biological barriers like the BBB. However, more extensive research is required so as to set up a firm base for the development of advanced commercial products based on carbon nanotubes for the treatment of Alzheimer’s disease.

8 October 2020 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SKSachin Kumar
Sachin Kumar
FFFaizana Fayaz
Faizana Fayaz
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
SBSakshi Bajaj
Sakshi Bajaj
SMSatish Manchanda
Satish Manchanda
HBHimangini Bansal
Himangini Bansal
Liver cancer is the fifth (6.3% of all cancers i.e., 548,000 cases/year) and ninth (2.8% of all cancers i.e., 244,000 cases/year) most prevalent cancer worldwide in men and women, respectively. Although multiple choices of therapies are offered for Hepatocellular Carcinoma (HCC) like liver resection or transplant, radiofrequency ablation, transarterial chemoembolization, radioembolization, and systemic targeted agent, by the time of diagnosis, most of the cases of HCC are in an advanced stage, which renders therapies like liver transplant or resection and local ablation impractical; and targeted therapy has its shortcomings like general toxicity, imprecise selectivity, several adversative reactions, and resistance development. Therefore, novel drugs with specificity and selectivity are needed to provide the potential therapeutic response. Various researches have shown the potential of phytomedicines in liver cancer by modulating cell growth, invasion, metastasis, and apoptosis. However, their therapeutic potential is held up by their unfavorable properties like stability, poor water solubility, low absorption, and quick metabolism. Nonetheless, the advancement of nanotechnology-based innovative nanocarrier formulations has improved the phytomedicines’ profile to be used in the treatment of liver cancer. Nanocarriers not only improve the solubility and stability of phytomedicines but also extend their residence in plasma and accomplish specificity. In this review, we summarize the advancements introduced by nanotechnology in the treatment of liver cancer. In particular, we discuss quite a few applications of nanophytomedicines like curcumin, quercetin, epigallocatechin-3-gallate, berberine, apigenin, triptolide, and resveratrol in liver cancer treatment.

1 October 2021 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
BKBhumika Kumar
Bhumika Kumar
MPMukesh Pandey
Mukesh Pandey
AMAshwini Kumar Mishra
Ashwini Kumar Mishra
ASAnjali Sharma
Anjali Sharma
FFFaizana Fayaz
Faizana Fayaz
FPFaheem Hyder Pottoo
Faheem Hyder Pottoo
Dementia is a diverse category of chronic and progressive disorder, which is commonly associated with a loss of memory, difficulty in judgment, impaired language, cognitive impairment, and various other symptoms that affect a person’s daily routine life and social life. Dementia affects about 50 million people around the globe. Dementia exists in varied forms and is associated with various neurodegenerative disorders. Alzheimer's disease is the most common form, which accords for about 60% of thecases. Abnormal agglomeration of proteins in the brain has been linked to the pathogenesis of dementia. Autophagy is a necessary protein clearance mechanism, which is dependent on lysosomes. It is a basic physiological process that performs the crucial function of maintaining protein homeostasis within the cells. The autophagic dysfunction in dementia further complicates the disease by hampering the degradation and removing abnormal pathogenic proteins. In order to understand autophagic dysfunction, it is essential to know the genetics of autophagy as well as the mutations This understanding at the genetic level helps definethe relationship between dementia and autophagic dysfunction for developing the potential remedies for the treatment of dementia.